Pulmonary fibrosis is an enduring and advancing pulmonary interstitial disease caused by
multiple factors that ultimately lead to structural changes in normal lung tissue. Currently …

Pulmonary fibrosis (PF) is a highly confounding and fatal pathological process with finite
treatment options. Multiple factors such as oxidative and immune/inflammation involve key …

Pulmonary fibrosis (PF) is a disease-refractive lung condition with an increased rate of
mortality. The potential factors causing PF include viral infections, radiation exposure, and …

Pulmonary fibrosis (PF) is the devastating consequence of various inflammatory diseases of
the lung. PF leads to a reduction of lung function, respiratory failure, and death. Several …

Pulmonary fibrosis (PF) is a lethal, chronic and progressive respiratory disease leading to
interstitial lung damage and serious breathing problems. The pathogenic mechanism …

Background Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease of unknown cause
which disrupts the normal lung architecture and functions by deregulating immune …

Ethnopharmacological relevance Pulmonary fibrosis (PF) is a chronic, debilitating and often
lethal lung disorder. Despite the molecular mechanisms of PF are gradually clear with …

Pulmonary fibrosis is a chronic progressive interstitial lung disease caused by a variety of
etiologies. The disease can eventually lead to irreversible damage to the lung tissue …

Pulmonary fibrosis (PF) is a chronic and irreversible pulmonary disease, and can lead to
decreased lung function, respiratory failure and even death. The pathogenesis research and …

Background: Pulmonary inflammation has got direct correlation with the progression of
various respiratory inflammatory disorders. Numerous respiratory chronic disorders such as …